Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H2 | P55055 | 1/20 | 0.41 |
| ▸ | SRC | P12931 | 8/20 | 0.37 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30181011 | 0.93 | NR1H2 (0.38) | NR1H2SRCCHRM2CHRM1CHRM3 | |
| SCHEMBL15273386 | 0.93 | NR1H2 (0.38) | NR1H2SRCCHRM2CHRM1CHRM3 | |
| SCHEMBL19942887 | 0.93 | NR1H2 (0.38) | NR1H2SRCCHRM2CHRM1CHRM3 | |
| SCHEMBL376323 | 0.93 | NR1H2 (0.38) | NR1H2SRCCHRM2CHRM1CHRM3 | |
| SCHEMBL13577617 | 0.93 | NR1H2 (0.38) | NR1H2SRCCHRM2CHRM1CHRM3 | |
| SCHEMBL28495607 | 0.93 | NR1H2 (0.38) | NR1H2SRCCHRM2CHRM1CHRM3 | |
| SCHEMBL23712837 | 0.87 | NR1H2 (0.44) | NR1H2SRCCHRM2CHRM1CHRM3 | |
| SCHEMBL26423420 | 0.84 | NR1H2 (0.43) | NR1H2SRCCHRM2CHRM1CHRM3 | |
| SCHEMBL23712705 | 0.84 | NR1H2 (0.43) | NR1H2SRCCHRM2CHRM1CHRM3 | |
| SCHEMBL29008007 | 0.82 | POLB (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116157392-A | Compounds targeting RNA binding proteins or RNA modification proteins | 雷多纳治疗公司 | 2023-05-23 | — | — | CN | disclosed |